Pharma Manufacturing
VerifiedMagazine
Pharmaceutical Manufacturing, the only publication devoted exclusively to drug manufacturing and scaleup, is dedicated to sharing best practices that will help drug industry professionals:
- Improve product quality while ensuring regulatory compliance
- Reduce cycle times, inventories and plant downtime and eliminate waste
- Empower manufacturing and operations staff
- Eliminate organizational and information silos
- Reduce time to market for new drugs—drugs that can actually be manufactured
Unlike broader publications that cover the entire pharmaceutical life cycle, Pharmaceutical Manufacturing‘s print and digital products focus on the manufacturing, quality and scaleup functions so critical to the industry’s future. Pharmaceutical Manufacturing’s editors search for examples of best practices from all over the world, so that readers can learn from their peers and the experts who are actively applying the principles of quality by design and scientific manufacturing, each and every day, at their facilities. Source
Actions
Media Outlet details
| Scope | Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
Recent Articles
Search ArticlesPiramal, Ajinomoto team on ADC development and manufacturing
Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology — a set of proprietary technologies designed to facilitate the creation of site-specific ADCs and linkers.
Biovac gets European backing for vaccine facility in Africa
The European Investment Bank Group, International Finance Corporation (IFC), and the European Commission announced a financing partnership to support development of a multi-vaccine manufacturing facility by Biovac aimed at expanding vaccine production capacity in Africa. The project includes a €75 million quasi-equity investment from EIB Group and a $20 million senior loan led by IFC, with additional financing under development.
Ardena opens Good Laboratory Practices bioanalytical lab in New Jersey
Ardena, a contract development and manufacturing organization and bioanalytical contract research organization, announced its new Good Laboratory Practices (GLP) bioanalytical laboratory in Somerset, New Jersey, is operational and supporting client studies. The 2,500-square-foot facility expands the company’s North American bioanalytical capabilities, providing services closer to U.S.-based development programs.
CEPI, Recipharm unit explore nuclear magnetic resonance for RNA vaccines
The Coalition for Epidemic Preparedness Innovations (CEPI) and Analysis Zero, a subsidiary of Recipharm, announced a collaboration to evaluate nuclear magnetic resonance (NMR) as a real-time process analytical technology (PAT) for RNA vaccine manufacturing. The project is focused on addressing bottlenecks in measuring critical quality attributes, which currently rely on multiple sequential assays that can take several days to complete, according to the organizations.
Grand River Aseptic Manufacturing invests $100M in sterile fill-finish capacity
Grand River Aseptic Manufacturing (GRAM), a U.S.-based contract development and manufacturing organization (CDMO) specializing in sterile fill-finish services, announced a $100 million investment to expand its sterile injectable manufacturing capacity. The investment includes a fifth sterile filling line and a fifth GMP facility designed to support high-volume commercial production of prefilled syringes and cartridges.
Kincell Bio augments Research Triangle Park facility for cell therapy manufacturing
Kincell Bio, a contract development and manufacturing organization (CDMO) focused on autologous and allogeneic cell therapies, announced an expansion of its Research Triangle Park (RTP), North Carolina facility to support late-stage development, commercial manufacturing, and lifecycle management. The RTP site, which serves as the company’s center for pivotal and commercial supply, will add two ISO 7 cleanroom suites, increasing capacity for commercial-scale cell therapy manufacturing.
Vetter expands clinical manufacturing network in US, Europe
Vetter, a Germany-based contract development and manufacturing organization (CDMO) focused on injectable drug products, announced progress in expanding its global clinical manufacturing network across the United States and Europe. The expansion is centered on scaling its development services to meet rising demand for early-stage manufacturing and in-human clinical trial materials.
Regeneron, Telix partner on radiopharmaceutical development
Telix Pharmaceuticals, a Melbourne, Australia-based radiopharmaceutical developer, and Regeneron Pharmaceuticals, headquartered in Tarrytown, New York, announced a collaboration to co-develop and commercialize next-generation radiopharma therapies. The agreement combines Telix’s radiopharma development and manufacturing platform with Regeneron’s antibody discovery and development capabilities, including bispecific antibody technologies.
OXB launches fast-track viral vector manufacturing service
Oxford Biomedica Solutions (OXB), a UK-based contract development and manufacturing organization, announced the launch of a fast-track development and manufacturing service designed to accelerate viral vector production for cell and gene therapy programs. The offering provides an expedited pathway to GMP manufacturing for adeno-associated viral (AAV) and lentiviral vectors, targeting biotech companies with time or funding constraints.
Avantor expands US quality control testing to support biomanufacturing
Avantor, a Pennsylvania-based provider of products and services for the life sciences and advanced technology industries, announced it has expanded quality control capabilities at its St. Louis, Missouri manufacturing site by adding microbial and stability testing. The enhanced facility introduces GMP-aligned microbial testing and ICH-compliant stability testing and storage in North America, supporting regulated biopharmaceutical manufacturing operations, the company said.